Literature DB >> 33047149

Risk Factors for Seborrhoeic Dermatitis Flares: Case-control and Case-crossover Study.

Rémi Lancar1, Pascale Missy, Alain Dupuy, Philippe Beaulieu, Laurence Fardet, Dominique Costagliola, Olivier Chosidow.   

Abstract

Patients with flares of seborrhoeic dermatitis were compared with control outpatients seen during the same time-period in a case-control study, and with themselves while in remission in a case-crossover study. All patients consulted the same office-based dermatologist. During the study period, 189 cases and 189 controls were included in the case-control study, and 81 cases in the case-crossover study. Multivariate analysis was performed. Case-control study results were the following: past history of tobacco consumption (odds ratio (OR) 2.2 (95% confidence interval (CI) 1.1-4.6)), conflict as a dispute during the past month (OR 10.6 (95% CI 1.0-114.3)), alcohol consumption on a regular basis (OR 10.2 (95% CI 2.0-52.6)), and higher level of stress during the past month (OR 8.2 (95% CI 3.4-19.9)). Case-crossover study results were the following: higher level of stress during the past month (OR 4.5 (1.7-12.2)), association borderline significant for higher level of alcohol consumption (OR 5.4 (0.8-34.9)). These risk factors for flares of seborrhoeic dermatitis should be taken into account carefully in the daily management of seborrhoeic dermatitis.

Entities:  

Keywords:  alcohol; stress; seborrhoeic dermatitis

Mesh:

Year:  2020        PMID: 33047149      PMCID: PMC9274933          DOI: 10.2340/00015555-3661

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  25 in total

1.  The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia.

Authors:  A Plunkett; K Merlin; D Gill; Y Zuo; D Jolley; R Marks
Journal:  Int J Dermatol       Date:  1999-12       Impact factor: 2.736

2.  High prevalence of seborrhoeic dermatitis on the face and scalp in mountain guides.

Authors:  M Moehrle; B Dennenmoser; B Schlagenhauff; S Thomma; C Garbe
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

3.  Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees.

Authors:  N Zander; R Sommer; I Schäfer; R Reinert; N Kirsten; B-C Zyriax; J-T Maul; M Augustin
Journal:  Br J Dermatol       Date:  2019-07-17       Impact factor: 9.302

4.  Seborrheic dermatitis: lifetime detection rates.

Authors:  I Palamaras; K P Kyriakis; N G Stavrianeas
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-04-27       Impact factor: 6.166

5.  [The French version of Skindex (Skindex-France). Adaptation and assessment of psychometric properties].

Authors:  A Leplège; E Ecosse; J Zeller; J Revuz; P Wolkenstein
Journal:  Ann Dermatol Venereol       Date:  2003-02       Impact factor: 0.777

6.  Seborrheic dermatitis and daylight.

Authors:  G Maietta; F Rongioletti; A Rebora
Journal:  Acta Derm Venereol       Date:  1991       Impact factor: 4.437

7.  Prevalence of skin disease in a cohort of shelter-based homeless men.

Authors:  A J Stratigos; R Stern; E González; R A Johnson; J O'Connell; J S Dover
Journal:  J Am Acad Dermatol       Date:  1999-08       Impact factor: 11.527

8.  Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts.

Authors:  N Sud; V Shanker; A Sharma; N L Sharma; M Gupta
Journal:  Int J STD AIDS       Date:  2009-09-24       Impact factor: 1.359

9.  [Stress and seborrheic dermatitis].

Authors:  L Misery; S Touboul; C Vinçot; S Dutray; G Rolland-Jacob; S-G Consoli; Y Farcet; N Feton-Danou; F Cardinaud; V Callot; C De La Chapelle; D Pomey-Rey; S-M Consoli
Journal:  Ann Dermatol Venereol       Date:  2007-11       Impact factor: 0.777

10.  Seborrheic dermatitis and hypertension in adults: a cross-sectional study.

Authors:  D Linder; J Dreiher; A Zampetti; F Sampogna; A D Cohen
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-11-23       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.